|The prevalence and outcome of effusive constrictive pericarditis: a systematic review of the literature.|
|Jump to Full Text|
|PMID: 22240903 Owner: NLM Status: MEDLINE|
|There is sparse information on the epidemiology of effusive constrictive pericarditis (ECP). The objective of this article was to review and summarise the literature on the prevalence and outcome of ECP, and identify gaps for further research. The prevalence of ECP ranged from 2.4 to 14.8%, with a weighted average of 4.5% [95% confidence interval (CI) 2.2-7.5%]. Sixty-five per cent (95% CI: 43-82%) of patients required pericardiectomy regardless of the aetiology. The combined death rate across the studies was 22% (95(CI: 4-50%). The prevalence of ECP is low in non-tuberculous pericarditis, while pericardiectomy rates are high and mortality is variable. In this review, of 10 patients identified with tuberculous ECP, only one presumed case had a definite diagnosis of ECP. Appropriate studies are needed to determine the epidemiology of ECP in tuberculous pericarditis, which is one of the leading causes of pericardial disease in the world.|
|Mpiko Ntsekhe; Charles Shey Wiysonge; Patrick J Commerford; Bongani M Mayosi|
Related Documents :
|23162593 - Neurofibromatosis type i (von recklinghausen's disease): a family case report and liter...
189973 - Bullous pemphigoid and rheumatoid arthritis with herpes simplex in the vesicular fluid.
7273993 - The classification of ultrastructural topography in the context of an ultrastructural d...
|Type: Journal Article; Review Date: 2012-01-12|
|Title: Cardiovascular journal of Africa Volume: 23 ISSN: 1680-0745 ISO Abbreviation: Cardiovasc J Afr Publication Date: 2012 Jun|
|Created Date: 2012-07-25 Completed Date: 2013-03-22 Revised Date: 2013-08-15|
Medline Journal Info:
|Nlm Unique ID: 101313864 Medline TA: Cardiovasc J Afr Country: South Africa|
|Languages: eng Pagination: 281-5 Citation Subset: IM|
|Cardiac Clinic, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa. firstname.lastname@example.org|
|APA/MLA Format Download EndNote Download BibTex|
Pericardial Effusion / epidemiology*, surgery
Pericardiectomy / adverse effects*
Pericarditis, Constrictive / epidemiology*, surgery
Pericarditis, Tuberculous / epidemiology, surgery
Journal ID (nlm-ta): Cardiovasc J Afr
Journal ID (iso-abbrev): Cardiovasc J Afr
Journal ID (publisher-id): TBC
Publisher: Clinics Cardive Publishing
www.cvja.co.zaCopyright © 2010 Clinics Cardive Publishing
Received Day: 14 Month: 6 Year: 2011
Accepted Day: 22 Month: 11 Year: 2011
Print publication date: Month: 6 Year: 2012
Volume: 23 Issue: 5
First Page: 281 Last Page: 285
PubMed Id: 22240903
|The prevalence and outcome of effusive constrictive pericarditis: a systematic review of the literature|
|Mpiko Ntsekhe, MD, PhD||
Affiliation: Cardiac Clinic, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa
|Patrick J Commerford, MBChB||
Affiliation: Cardiac Clinic, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa
|Bongani M Mayosi, DPhil (Oxon)||
Affiliation: Cardiac Clinic, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa
|Charles Shey Wiysonge, MD||
Affiliation: Institute of Infectious Disease and Molecular Medicine, and School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa
Effusive constrictive pericarditis (ECP) is a clinical haemodynamic syndrome in which constriction of the heart by the visceral pericardium occurs in the presence of a compressive pericardial effusion. ECP is believed to be a rare manifestation of pericardial disease1 that occurs as part of a continuum from effusive to constrictive pericarditis. The outcome of ECP with regard to the development of constrictive pericarditis, pericardiectomy rates and death is not well defined.2 In the only prospective study of ECP, the prevalence was 6.8% of patients undergoing pericardiocentesis and 1.2% of all patients referred with effusive pericarditis.3 In the same study, 46.7% of participants with the diagnosis underwent pericardiectomy within four months, and the overall mortality rate was 60% over the subsequent seven-year mean follow-up period.3
The influence of the aetiology of pericarditis on the prevalence and outcome of ECP is not known. For example, tuberculous pericarditis is associated with significant inflammation,4 chronicity,5 and a high rate of development of constrictive pericarditis in about 25% of cases.5-7 It is likely therefore that the prevalence of ECP in patients with tuberculous pericarditis may be much higher than seen in acute forms of pericardial disease, such as idiopathic or viral pericarditis, which have formed the basis of the previous studies of ECP.8
With regard to the natural history, in the study of Sagrista-Sauleda, those with neoplastic disease had a high mortality and low pericardiectomy rate, whereas those with idiopathic disease had a low mortality rate but high pericardiectomy rate.3 The impact of the aetiology of pericarditis on these outcomes of ECP among patients whose life expectancy is not severely limited by malignant disease is not known.
There are very few investigators who have used the ‘gold standard’ to establish the diagnosis of ECP, which is invasive measurement of intra-pericardial and intra-cardiac pressures before and after pericardiocentesis.2 Even though non-invasive tools, such as echocardiography and magnetic resonance imaging are gaining wider acceptance as methods for establishing the diagnosis,9 none has been compared to invasive haemodynamic diagnosis of ECP.9,10
It has been proposed that visceral pericardiectomy may be necessary for a good clinical result in cases with ECP because drainage of pericardial fluid alone leads to incomplete relief of cardiac compression.3 The timely recognition of ECP therefore enables the clinician to choose the most appropriate therapy. Information about the prevalence and outcome of ECP is particularly important in the developing world, where tuberculosis causes hundreds of thousands of cases of pericarditis every year.5 There are at present no recommendations on the diagnosis and management of ECP in tuberculous pericarditis.
We have conducted a systematic review of the literature to determine the prevalence and outcome of ECP in patients with viral, tuberculous, uraemic, purulent and idiopathic pericarditis. The outcomes of interest were pericardiectomy and mortality rates at 12 months. Furthermore, we determined whether the prevalence and the outcome of ECP were related to the aetiology of the effusion. We limited the review to observational studies of pericarditis due to these non-neoplastic medical conditions that commonly progress to constrictive pericarditis.1
MEDLINE, EMBASE and Google Scholar were searched for English-language publications of observational studies of ECP that were conducted from inception of the respective database through to December 2009. Search terms included: acute pericarditis, pericardial effusion, ECP, pericardial tamponade, cardiac tamponade, tuberculous pericarditis, uraemic pericarditis, purulent pericarditis, idiopathic pericarditis, viral pericarditis and constrictive pericarditis. Limits included: the English language, human beings and the following MeSH terms (‘Case-Control Studies’[MeSH] OR ‘Cohort Studies’[MeSH] OR ‘Epidemiologic Studies’[MeSH] OR ‘Cross-Sectional Studies’[MeSH] OR ‘Retrospective Studies’[MeSH] OR ‘Prospective Studies’[MeSH]). In addition to searching the databases, we contacted researchers in the field, and searched the bibliographies of published reviews and studies on pericardial disease for relevant studies.
The eligibility criteria for inclusion and exclusion from the study, which are based on the Loney criteria for critical appraisal of research articles on prevalence of disease, are shown in Table 1., 11 To be included in the review, a study had to provide sufficient information to enable determination of the proportion of study participants diagnosed with ECP and at least six other eligibility criteria.
Studies where malignancy was the predominant cause of pericarditis were excluded from this systematic review because patients with this diagnosis generally do not survive long enough to develop constrictive pericarditis.1,12 Studies of patients with pericardial effusion that resulted from aortic dissection, myocardial infarction, and trauma to the thorax were also excluded because pericardial sequelae are uncommon among long-term survivors of these conditions.1,13-15
After the relevant studies were selected, individual patient data were extracted and reviewed in order to exclude patients with malignancy-associated ECP. Where relevant data could not be extracted from the published manuscripts, we were able to obtain the information on individual participants from the study authors. We conducted a meta-analysis of the individual patient data using the StatsDirect software (www.statsdirect.com). For the meta-analysis, StatsDirect first transformed proportions into a quantity (the Freeman-Tukey variant of the arcsine square root-transformed proportion) suitable for the usual fixed and random-effects summaries.16,17 The pooled prevalence was calculated as the back-transform of the weighted mean of the transformed proportions, using inverse arcsine variance weights for the fixed-effects model16 and DerSimonian-Laird17 weights for the random-effects model.
We used the Cochran Q test to assess statistical heterogeneity between studies and, in the absence of significant heterogeneity (p > 0.1), combined the data using a fixed-effects method. Otherwise, we used the random-effects method. In addition, we used Higgins I2 statistic to quantify inconsistency across the studies included in the meta-analysis. The test statistic describes the percentage of the variability in effect it estimates that is due to true heterogeneity rather than chance. The closer the I2 value is to 100%, the more likely it is that true heterogeneity exists, and therefore the less reliable the combined estimate becomes.
MN conducted the electronic searches and selected the studies, all of which were reviewed by CW and BMM. The reporting of the systematic review is in keeping with standard recommendations for reporting systematic reviews of observational studies.18
Effusive constrictive pericarditis was classified as definite or probable, based on the methods used to establish the diagnosis.2,9 Studies where the diagnosis was based on clinical assessment alone were rejected.
Patients were classified as having definite ECP if the diagnosis was based on intra-pericardial and intra-cardiac haemodynamics, determined before and after pericardiocentesis. This haemodynamic definition required that: (1) the pre-pericardiocentesis transmural filling pressure (i.e. the difference between the elevated intra-pericardial pressure and the right atrial pressure) was less than 2 mmHg; (2) the post-pericardiocentesis intra-pericardial pressure fell to near 0 mmHg; and (3) the post-pericardiocentesis right atrial pressure failed to fall by 50% or to a level below 10 mmHg.3
The diagnosis of ECP was considered probable if it was established on the basis of echocardiography or magnetic resonance imaging. There are no published prospectively derived consensus diagnostic criteria for ECP using these imaging modalities,9 but widely accepted criteria include evidence of the following criteria in a patient with a pericardial effusion: (1) pericardial thickening; (2) abnormal or paradoxical movement of the interventricular septum; (3) a plethoric dilated inferior vena cava with reduced narrowing during inspiration; and (4) marked respiratory variation of the mitral inflow Doppler pattern. Finally, the diagnosis of ECP was rejected if it was established without ancillary imaging or haemodynamic assessment, i.e. if the diagnosis was made on clinical assessment alone.
A flow chart for the selection process is provided in Fig. 1. Five studies were included in the systematic review.3,19-22 The five studies had a total of 642 patients, 26 of whom met diagnostic criteria for ECP; 58% (15/26) had probable ECP and 42% (11/26) definite ECP. Of the 26 patients, 50% (13/26) had idiopathic pericarditis, 38% (10/26) had tuberculous pericarditis, 8% (2/26) had post-radiation pericarditis and 4% (1/26) post-pericardiotomy pericarditis.
The study design and strength of diagnosis of ECP varied across the five selected studies. Three of the five studies were prospective cohorts.3,19,21 One of the three prospective case series was a single-centre South African study, designed to determine the 30-day and one-year outcomes of consecutive patients with predominantly tuberculous pericarditis, who were each given a standardised therapeutic protocol, which included pericardiocentesis.19 The proportion of those with ECP was 2.6% based on clinical and echocardiographic criteria.
The second prospective case series was a single-centre French study designed to determine the role of surgical pericardioscopy as a diagnostic tool among patients with large pericardial effusion of uncertain aetiology.21 The proportion of patients diagnosed with ECP was reported as 1.4%. All patients underwent pericardiocentesis, and echocardiography was used to assess pericardial physiology and content.
The third prospective case series was a single-centre Spanish study, which aimed to determine the prevalence of ECP and the incidence of pericarditis-related outcomes over a median follow-up period of seven years.3 Consecutive participants presenting with a diagnosis of pericardial tamponade over 15 years underwent measurement of the pre- and post-pericardiocentesis intra-pericardial and right atrial pressures. The prevalence of ECP was 5.8% in those patients undergoing pericardiocentesis, 6.8% in those with clinical tamponade, and 0.93% in patients with any pericardial disease.3
The remaining two studies of patients with a probable diagnosis of ECP were designed to (1) determine the long-term outcome of patients with symptomatic effusion;22 and (2) compare echocardiographic differences between tuberculous and idiopathic pericardial effusions.20 The prevalence of ECP in these two studies was 4.3 and 14.8%, respectively.
Overall there was significant variability in the prevalence of ECP across the five studies (p = 0.04; I2 = 61%); therefore we used both the random-effect and fixed-effect meta-analysis models to combine the prevalence. Using the fixed-effect model, the pooled prevalence of ECP in the five studies was 4.0% (95% CI: 2.7–5.7%). This increased marginally to 4.5% (95% CI: 2.2–7.5%) using the random-effects model (Fig. 2).
Two of the nine patients were dead at 12 months; one from peri-operative complications, and the other with tuberculous ECP died while awaiting pericardiectomy. The combined death rate across the studies was 22%, with wide 95% confidence intervals (4–50%) due to the small numbers involved. Seven patients did not undergo pericardiectomy. These seven included: the patient with tuberculosis who died from heart failure while awaiting surgery, three participants, also with tuberculosis, who did not consent to the procedure, and three participants with idiopathic disease in whom a conservative ‘wait-and-see’ approach had been adopted. The six participants, who survived the early stages of their illness without surgery were alive and well at their last follow-up visit.
Only three of the studies provided data on the pericardiectomy rates.3,19,22 Overall, the combined pericardiectomy rate was 65% (95% CI: 43–82%) and the between-study variability in pericardiectomy rates was marginally significant (p = 0.10; I2 = 56%). A breakdown of the pericardiectomy rates by aetiology revealed that 73% of participants with idiopathic ECP, 60% of those with tuberculous ECP, and 50% of those with ECP of other aetiologies underwent the pericardiectomy.
The persistence of heart failure was the reason for surgery in 54% of cases, making it the most common indication, followed by prophylaxis against progression to fibrous constrictive pericarditis in 23%. Recurrence of pericardial effusion was an indication in 15%. In only 8% was the operation performed because of progression to non-effusive fibrous constrictive pericarditis.
This systematic review highlights that there are very few prospective studies on the prevalence and outcome of ECP. The prevalence of this syndrome in the available studies ranged from 1.4 to 14%. Although there was little information to ascertain the mortality rate reliably, the pericardiectomy rate was clearly high (44–100%).
There was a total of 10 participants who had effusive constrictive tuberculous pericarditis in this review, one of whom had a definite diagnosis of ECP. Commerford and Strang have suggested that ECP may be a common form of presentation of tuberculous pericarditis that frequently progresses to fibrous constrictive pericarditis.8 By contrast, the IMPI Africa Registry has suggested that using clinical criteria alone, ECP may be present in only 15% of cases of tuberculous pericarditis.23
The results of this comprehensive review show a low prevalence of ECP in patients with tuberculous pericarditis, which ranged from 3 to 14%. It is noteworthy that there are no studies that have systematically used an invasive haemodynamic method to establish the diagnosis of effusive constrictive disease in patients with tuberculous pericarditis. There is therefore a need for a definitive study of the prevalence of tuberculous ECP that is based on invasive haemodynamic methods.
Although the pericardiectomy rate across the studies was high, the indications for surgical intervention were not uniform among the 13 participants who had the operation. A significant proportion of patients who were managed conservatively had complete resolution of their effusive constrictive disease. This suggests that there is room for a study to test a strategy of watchful waiting compared to prophylactic pericardiectomy in those without persistence of heart failure.
Finally, the mortality rate for tuberculous pericarditis in the HIV era is as high as 40% in patients with AIDS, at the end of six months of treatment with anti-tuberculosis medication.24 Despite the absence of data on mortality in patients with non-neoplastic ECP, it is possible that because of its well-documented haemodynamic sequelae,2 the pericardial syndrome is associated with a higher mortality rate than those without the syndrome.
In light of the lack of clarity on the prevalence of ECP among patients with proven tuberculous pericarditis, the role of prophylactic pericardiectomy in cases of varying aetiology, and the impact of the syndrome on mortality, a study of well-characterised participants with adequate follow up and clearly defined outcomes is required to inform the development of clinical guidelines on the diagnosis and management of effusive constrictive pericardial disease.
|1.||Cameron J,Oesterle SN,Baldwin JC,Hancock EW,The etiologic spectrum of constrictive pericarditis.Am Heart JYear: 19871132 Pt 13543603812191|
|2.||Hancock EW,A clearer view of effusive-constrictive pericarditis.New Engl J MedYear: 2004350543543714749449|
|3.||Sagrista-Sauleda J,Angel J,Sanchez A,Permanyer-Miralda G,Soler-Soler J,Effusive-constrictive pericarditis.N Engl J MedYear: 2004350546947514749455|
|4.||Reuter H,Burgess LJ,Carstens ME,Doubell AF,Characterization of the immunological features of tuberculous pericardial effusions in HIV positive and HIV negative patients in contrast with non-tuberculous effusions.Tuberculosis (Edinb)Year: 200686212513316360340|
|5.||Mayosi BM,Burgess LJ,Doubell AF,Tuberculous pericarditis.CirculationYear: 2005112233608361616330703|
|6.||Desai HN,Tuberculous pericarditis. A review of 100 cases.S Afr Med JYear: 19795522877880472922|
|7.||Schrire V,Experience with pericarditis at Groote Schuur Hospital, Cape Town: an analysis of one hundred and sixty cases studied over a six-year period.S Afr Med JYear: 19593381081714443596|
|8.||Commerford PJ,Strang JIG. Tuberculous pericarditis.Coovadia HM,Benatar SRA Century of Tuberculosis South African Perspectives.1st edn.Capetown:Oxford University PressYear: 1991123137|
|9.||Zagol B,Minderman D,Munir A,D’Cruz I,Effusive constrictive pericarditis: 2D, 3D echocardiography and MRI imaging.EchocardiographyYear: 200724101110111418001370|
|10.||Grizzard JD,Magnetic resonance imaging of pericardial disease and intracardiac thrombus.Heart Fail ClinYear: 200953401419, vii19564016|
|11.||Loney PL,Chambers LW,Bennett KJ,Roberts JG,Stratford PW,Critical appraisal of the health research literature: prevalence or incidence of a health problem.Chronic Dis CanYear: 199819417017610029513|
|12.||Colombo A,Olson HG,Egan J,Gardin JM,Etiology and prognostic implications of a large pericardial effusion in men.Clin CardiolYear: 19881163893943293859|
|13.||Ling LH,Oh JK,Schaff HV,Danielson GK,Mahoney DW,Seward JB,et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy.CirculationYear: 1999100131380138610500037|
|14.||Correale E,Maggioni AP,Romano S,Ricciardiello V,Battista R,Salvarola G,et al. Comparison of frequency, diagnostic and prognostic significance of pericardial involvement in acute myocardial infarction treated with and without thrombolytics. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI).Am J CardiolYear: 19937116137713818517380|
|15.||Correale E,Maggioni AP,Romano S,Ricciardiello V,Battista R,Santoro E,Pericardial involvement in acute myocardial infarction in the post-thrombolytic era: clinical meaning and value.Clin CardiolYear: 19972043273319098589|
|16.||Mantel N,Haenszel W,Statistical aspects of the analysis of data from retrospective studies of disease.J Natl Cancer InstYear: 195922471974813655060|
|17.||DerSimonian R,Laird N,Meta-analysis in clinical trials.Control Clin TrialsYear: 1986731771883802833|
|18.||Stroup DF,Berlin JA,Morton SC,Olkin I,Williamson GD,Rennie D,et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting.J Am Med AssocYear: 20002831520082012|
|19.||Reuter H,Burgess LJ,Louw VJ,Doubell AF,The management of tuberculous pericardial effusion: experience in 233 consecutive patients.Cardiovasc J South AfrYear: 20071812025|
|20.||George S,Salama AL,Uthaman B,Cherian G,Echocardiography in differentiating tuberculous from chronic idiopathic pericardial effusion.HeartYear: 200490111338133915486140|
|21.||Nugue O,Millaire A,Porte H,de Groote P,Guimier P,Wurtz A,et al. Pericardioscopy in the etiologic diagnosis of pericardial effusion in 141 consecutive patients.CirculationYear: 1996947163516418840855|
|22.||Tsang TS,Barnes ME,Gersh BJ,Bailey KR,Seward JB,Outcomes of clinically significant idiopathic pericardial effusion requiring intervention.Am J CardiolYear: 200391670470712633802|
|23.||Mayosi BM,Wiysonge CS,Ntsekhe M,Volmink JA,Gumedze F,Maartens G,et al. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry.BMC Infect DisYear: 20066216396690|
|24.||Mayosi BM,Wiysonge CS,Ntsekhe M,Gumedze F,Volmink JA,Maartens G,et al. Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa.S Afr Med JYear: 2008981364018270639|
[Figure ID: F1]
Flow chart for selection process.
[Figure ID: F2]
Forest plot for the prevalence of ECP (random effects).
|1. The study design was observational (case control, cross sectional and cohort); cross sectional studies were accepted for the determination of prevalence.|
|2. A definition of the syndrome of effusive constrictive pericarditis was given.|
|3. The inclusion and exclusion criteria for the participants were clearly stated.|
|4. There was a clear description of the number of participants in the study.|
|5. The number or proportion of participants in the study with effusive constrictive pericarditis was clearly stated.|
|6. The method of diagnosis of effusive constrictive pericarditis was described and determined in an unbiased manner.|
|7. There was an adequate description of the study setting.|
|8. There was an adequate description of the study population.|
|1. The number or proportion of participants with effusive constrictive pericarditis was not available.|
|2. The aetiology of pericarditis was a malignancy, myocardial infarction, aortic dissection, or trauma to the thorax.|
|3. The diagnosis of effusive constrictive pericarditis was based on clinical assessment only.|
|Study||Absolute number of study participants with non-neoplastic ECP||Number of patients with ECP who underwent pericardiectomy within 12 months||Number of patients with ECP dead at 12 months|
|Sagrista-Sauleda 2004||11||7/11 (64%)||Mortality data at 12 months not available for all patients|
|Reuter 2007||5||2/5 (40%)||2/5 (40%)|
|Tsang 2003||4||4/4 (100%)||0/4 (0%)|
|Nugue 1996||2||Pericardiectomy data not available||Mortality data not available|
|George 2004||4||Pericardiectomy data not available||Mortality data not available|
|Total||26||13/20 (65%)||2/9 (22%)|
Keywords: effusive constrictive pericarditis, prevalence, pericardiectomy and death.
Previous Document: Dopamine Affects the Change of Pain-Related Electrical Activity Induced by Morphine Dependence.
Next Document: Locally enhanced concentration and detection of oligonucleotides in a plug-based microfluidic device...